Apotex Pty Ltd v ICOS Corporation (No 4) [2018] FCA 1316
The Court made final orders declaring threatened infringement, certifying that the validity of specified claims of the '946 Patent and the '666 Patent had been unsuccessfully questioned, and restraining Apotex from infringing or threatening to infringe those claims. The Court rejected Apotex's objections to inclusion of a standard penal notice. However, prohibitions referring to making or offering to make products were removed because they did not relate to the facts of the case, and the proposed PBS listing commitment or guarantee prohibitions were refused because, although such conduct could be threatened infringement or a proper ancillary restraint, the issue had not been litigated,...
- Jurisdiction
- Australia
- Judgment Date
- 24 August 2018
- Procedural Posture
- Patent Proceeding Concerning Declarations of Invalidity, Revocation, Threatened Infringement and Injunctive Relief / Final Declarations, Certifications and Orders After Reasons for Judgment
- Outcome
- Final orders made; Apotex's Originating Application dismissed; ICOS' amended Notice of Cross-claim otherwise dismissed; injunctions granted in modified form; Apotex ordered to pay ICOS' costs subject to specified prior costs orders.
- Legal Topics
- ['patent Infringement' 'threatened Infringement' 'validity Certificates' 'final Injunctions' 'penal Notices' 'pbs Listing Commitments or Guarantees' 'confidentiality Orders']
Case Brief
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Procedural Posture
Patent Proceeding Concerning Declarations of Invalidity, Revocation, Threatened Infringement and Injunctive Relief / Final Declarations, Certifications and Orders After Reasons for Judgment
Legal Issues
- 1 ['Whether final orders should include a penal notice where the orders include patent injunctions against a corporation.' 'Whether the particular injunctive prohibitions referring to making or offering to make Tadalafil products should be included.' 'Whether injunctions should restrain making or maintaining a commitment or guarantee in connection with an application to list Tadalafil products on the Schedule of Pharmaceutical Benefits or the Repatriation Schedule of Pharmaceutical Benefits.' 'Whether such PBS listing commitment or guarantee conduct could be characterised as threatened infringement or as conduct properly restrained by an ancillary order.']
Ratio Decidendi
The Court made final orders declaring threatened infringement, certifying that the validity of specified claims of the '946 Patent and the '666 Patent had been unsuccessfully questioned, and restraining Apotex from infringing or threatening to infringe those claims. The Court rejected Apotex's objections to inclusion of a standard penal notice. However, prohibitions referring to making or offering to make products were removed because they did not relate to the facts of the case, and the proposed PBS listing commitment or guarantee prohibitions were refused because, although such conduct could be threatened infringement or a proper ancillary restraint, the issue had not been litigated,...
Court Disposition
Final orders made; Apotex's Originating Application dismissed; ICOS' amended Notice of Cross-claim otherwise dismissed; injunctions granted in modified form; Apotex ordered to pay ICOS' costs subject to specified prior costs orders.
Orders
- ['The Court declared that Apotex had threatened to infringe claims 1-6, 8-17, 19-29 and 31-35 of Australian Patent No. 769946.' 'The Court declared that Apotex had threatened to infringe claims 1-3, 5-8, 10-12, 14-18 and 24-38 of Australian Patent No. 773666.' "Pursuant to section 19(1) of the Patents Act 1990...
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment